Autolus Therapeutics plc
AUTL
$1.51
-$0.06-3.82%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 11,255.01% | -96.67% | |||
| Gross Profit | -11,252.63% | 96.67% | |||
| SG&A Expenses | 55.43% | 24.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.18% | 15.62% | |||
| Operating Income | -12.14% | -15.62% | |||
| Income Before Tax | 68.15% | -40.97% | |||
| Income Tax Expenses | 6,545.45% | -56.86% | |||
| Earnings from Continuing Operations | 66.37% | -40.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 66.37% | -40.88% | |||
| EBIT | -12.14% | -15.62% | |||
| EBITDA | -12.28% | -16.06% | |||
| EPS Basic | 66.39% | -40.87% | |||
| Normalized Basic EPS | 68.23% | -41.61% | |||
| EPS Diluted | 66.39% | -40.87% | |||
| Normalized Diluted EPS | 68.23% | -41.61% | |||
| Average Basic Shares Outstanding | 0.04% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.04% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
